Skip to main content

Table 1 Baseline characteristics of the study subjects

From: Hemoglobin concentration; a pathway to frailty

Baseline Characteristic (N = 1905)

 
 

Available data

Included (N = 1829)

Socio-demographic

 Age, mean (SD), years

1905

82.44 (6.50)

 Gender, Male, n(%)

1905

597 (32.64)

 School education, n(%)

  

 Low level of education

1811

677 (37.01)

 Middle level of education

 

711 (38.87)

 High level of education

 

357 (19.52)

 Living arrangements n(%)

  

 Living alone

1874

842 (46.04)

 Living with others

 

959 (52.43)

Health conditions

 Hypertension n(%)

1814

952 (52.05)

 Diabetes mellitus n(%)

1814

261 (14.27)

 Atrial arrhythmia n(%)

1811

278 (15.20)

 Thrombo embolic disease n(%)

1808

141 (7.71)

 Cardiovascular disease n(%)

1810

269 (14.71)

 Congestive heart failure n(%)

1813

103 (5.63)

 Chronic respiratory disease n(%)

1269

17 (0.93)

 Renal insufficiency n(%)

1269

57 (3.12)

 Connectivitis n(%)

1814

62 (3.39)

 Prebaseline cancer n(%)

1814

337 (18.43)

Examination findings

 Frailty Fried’s criteria

  

 Non frail

1886

936 (51.18)

 Frail

 

893 (48.82)

 Cognitive: MMSE score (%)

  

 No impairment ≥26

1851

961 (52.54)

 Mild impairment 21–25

 

484 (26.46)

 Moderate impairment 11–20

 

310 (16.95)

 Severe impairment 0–10

 

27 (1.48)

 Nutritional status

  

 MNA score ≥ 24

1847

1084 (59.27)

 MNA score 17–23.5

 

610 (33.35)

 MNA score < 17

 

81 (4.43)

 ADL score(/6), median (IQR)

1899

6 (1)

 IADL score(/8), median (IQR)

1884

6 (4)

Laboratory results

 Hemoglobin, Mean ± SD g/dl

1854

13.33 (1.41)

 Mean corpuscular volume, median (IQR), fl

1854

91 (6)

 White blood cell count, median (IQR), 10^3/cm

1854

6.63 (2.38)

 Platelets, median (IQR), 10^3/cm

1832

231 (80)

 Anemia n(%)

1832

381 (20.83)

 C-reactive protein, median (IQR), mg/L

1861

2.1 (3.9)

Renal function: CKD-EPI MD

 Normal (eGFR ≥90 ml/min/1.73m2), n(%)

1875

162 (8.86)

 Mild decrease (eGFR 60–89 ml/min/1.73m2), n(%)

 

1120 (61.24)

 Moderate to severe decrease (eGFR 30–59 ml/min/1.73m2), n(%)

 

484 (26.46)

 Severe decrease (eGFR≤29 ml/min/1.73m2), n(%)

 

43 (2.35)

  1. SD Standard deviation, IQR Inter quartile; MMSE: Mini mental state examination, MNA Mini nutritional assessment, ADL Activities of daily living, IADL Instrumental activities of daily living
  2. Cardiovascular disease: Arrythmia, coronary artery disease, pulmonary hypertension, heart valve problems, congestive heart failure, hypertension, cholesterol, obliterating artery disease, thrombosis, pulmonary embolism;Cancer: leukemia, lymphoma, multiple myeloma, solid cancer
  3. CKD-EPI MD: Chronic kidney disease epidemiology collaboration; eGFR: Equations for glomerular filtration rate